822 related articles for article (PubMed ID: 26423779)
1. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Vallet-Pichard A; Pol S
Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
[TBL] [Abstract][Full Text] [Related]
2. Viral hepatitis in solid organ transplantation other than liver.
Vallet-Pichard A; Fontaine H; Mallet V; Pol S
J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on dual hepatitis B and C infection in Taiwan.
Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH
J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
[TBL] [Abstract][Full Text] [Related]
5. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
Liu CJ
J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
[TBL] [Abstract][Full Text] [Related]
6. [Prevention and treatment of viral hepatitis in renal insufficiency conditions].
Fontaine H; Pol S
Nephrologie; 2001; 22(7):339-47. PubMed ID: 11817211
[TBL] [Abstract][Full Text] [Related]
7. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
[TBL] [Abstract][Full Text] [Related]
8. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
[TBL] [Abstract][Full Text] [Related]
9. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
[TBL] [Abstract][Full Text] [Related]
10. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
Potthoff A; Berg T; Wedemeyer H;
Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of viral hepatitis in solid organ transplantation].
Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
[TBL] [Abstract][Full Text] [Related]
12. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis C infections in dialyzed patients].
Podlasin RB
Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
[TBL] [Abstract][Full Text] [Related]
14. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.
Li LF; Shi KQ; Lin YQ; Wang LR; He JP; Braddock M; Chen YP; Zheng MH
Gene; 2014 Jul; 544(2):101-6. PubMed ID: 24793583
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Kamar N; Ribes D; Izopet J; Rostaing L
Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
[TBL] [Abstract][Full Text] [Related]
19. Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.
Takagi H; Hoshino T; Naganuma A; Koitabashi E; Uehara S; Sakamoto N; Kudo T; Ryusaki K; Kakizaki S; Okamoto H
Hepatogastroenterology; 2013 Oct; 60(127):1557-60. PubMed ID: 24627926
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hepatitis C in patients on renal replacement therapy].
Tornai I; Mátyus J
Orv Hetil; 2007 Mar; 148(11):489-94. PubMed ID: 17350920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
